Xenon Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals | DEF 14A: Definitive information statements
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals | DEF 14A: Definitive proxy statements
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
No Data